7 million will worry when Medicare coverage of anxiety drugs ceases When the U.

Government’s new prescription drug benefit begins next year a category of drugs frequently used to treat anxiety, seizures and insomnia will never be included. This will mean that those elderly and disabled people on Medicare who take Xanax, Valium, Atvian and other styles of the medication, benzodiazepine, will need to find other means of coverage or switch to a new, less addictive medicine.7 million low-income, elderly people who take the drug finding other alternatives might not be that easy. Although they will be automatically enrolled in the brand new prescription drug plan, they will be dependant on the states to keep spending money on their benzodiazepines but there is absolutely no guarantee that will happen.The peer-review procedure used in Hindawi’s journals depends generally on the expertise of its editorial board members and the guest editors of special issues, who are responsible for supervising the review of submitted manuscripts.5 Because the peer reviewers chosen by the guest editors were not subject to any kind of independent verification, editors themselves could undermine the procedure in quite similar way that authors or third-party agencies have done elsewhere: by creating fake reviewer identities and addresses that they submitted reviews that are positive endorsing publication. When all manuscripts dealt with by these editors had been examined, a complete of 32 articles were identified that had been accepted thanks to the comments of false reviewers. It is unclear what motivated the guest editors to engage in such fraud, nor provides it been determined if the authors of the manuscripts included participated in the deception in any way.